Literature DB >> 11852428

Photodynamic therapy with indocyanine green for occult subfoveal choroidal neovascularization caused by age-related macular degeneration.

R A Costa1, M E Farah, J A Cardillo, R Belfort.   

Abstract

PURPOSE: To report two cases of occult subfoveal choroidal neovascularization (CNV) due to age-related macular degeneration (AMD) that were successfully treated utilizing large spot, low irradiance 810-nm light and intravenous injection of small-volume, high-concentration indocyanine green (ICG) bolus, termed ICG-mediated photodynamic therapy (i-PDT).
METHODS: Case report. Two patients with occult subfoveal CNV (two eyes) due to AMD were treated with i-PDT and were prospectively followed with fluorescein and indocyanine green angiography as well as optical coherence tomography (OCT).
RESULTS: Both patients presented a 3-line increase in visual acuity by twelve months of follow-up. A significant regression of the CNV was demonstrated by fluorescein angiography within one week following treatment. OCT revealed diminishing of the subretinal fluid. There were no complications related to the procedure.
CONCLUSION: i-PDT induced CNV regression and improved the visual acuity in these particular cases, suggesting a new and promising way to treat neovascular AMD. The partial anatomical restoration associated to the improvement of the visual function observed in both patients suggests that a selective therapeutic effect was achieved. Further studies are required not only to assess the clinical value of this treatment but also to better understand the major mechanism of action involving this novel treatment modality.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11852428     DOI: 10.1076/ceyr.23.4.271.5449

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  9 in total

1.  Indocyanine green-mediated photothrombosis with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration.

Authors:  J Fernando Arevalo; Reinaldo A Garcia; Aristides J Mendoza
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-05-20       Impact factor: 3.117

2.  Neovascular ingrowth site photothrombosis in choroidal neovascularization associated with retinal pigment epithelial detachment.

Authors:  Rogério A Costa; Karolinne M Rocha; Daniela Calucci; José A Cardillo; Michel E Farah
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-02-19       Impact factor: 3.117

3.  Indocyanine green mediated photothrombosis for the management of predominantly classic choroidal neovascularisation caused by age related macular degeneration.

Authors:  M E Farah; J A Cardillo; A C Luzardo; D Calucci; G A Williams; R A Costa
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

4.  Application of femtosecond ultrashort pulse laser to photodynamic therapy mediated by indocyanine green.

Authors:  M Sawa; K Awazu; T Takahashi; H Sakaguchi; H Horiike; M Ohji; Y Tano
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

5.  Indocyanine green enhanced subthreshold diode-laser micropulse photocoagulation treatment of chronic central serous chorioretinopathy.

Authors:  F Ricci; F Missiroli; F Regine; M Grossi; G Dorin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-17       Impact factor: 3.117

6.  Indocyanine-green-mediated photothrombosis (IMP) with intravitreal triamcinolone acetonide for macular edema secondary to group 2A idiopathic parafoveal telangiectasis without choroidal neovascularization: a pilot study.

Authors:  J Fernando Arevalo; Juan G Sanchez; Reinaldo A Garcia; Lihteh Wu; Maria H Berrocal; Francisco J Rodriguez; Alvaro Rodríguez; Liliana Andrea Novoa; Rafael Garcia-Amaris
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-07-10       Impact factor: 3.117

Review 7.  Photodynamic therapy in treatment of oral lichen planus.

Authors:  Diana Mostafa; Bassel Tarakji
Journal:  J Clin Med Res       Date:  2015-04-08

8.  Combination of Near Infrared Light-Activated Photodynamic Therapy Mediated by Indocyanine Green with Etoposide to Treat Non-Small-Cell Lung Cancer.

Authors:  Ting Luo; Qinrong Zhang; Qing-Bin Lu
Journal:  Cancers (Basel)       Date:  2017-06-05       Impact factor: 6.639

9.  Indocyanine green mediated photothrombosis and high dose intravitreal bevacizumab as adjuvant therapy for isolated choroidal metastasis from breast cancer.

Authors:  J Fernando Arevalo; Juan V Espinoza
Journal:  J Ophthalmic Vis Res       Date:  2012-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.